Corrigendum to ‘Au-Polydopamine integrated polycaprolactone-based 2D plasmonic nanofibrous bimodal platform for synergistically enhanced peripheral neuropathy and superior cancer theranostics’ [Materials Today Chemistry 41 (2024) 102294] (Materials Today Chemistry (2024) 41, (S2468519424004002), (10.1016/j.mtchem.2024.102294))

Research output: Contribution to journalComment/debate

Abstract

The authors regret <there is an addition to third corresponding author Kyung Hyun Min's affiliation>. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number102335
JournalMaterials Today Chemistry
Volume41
DOIs
StatePublished - 2024.10

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Quacquarelli Symonds(QS) Subject Topics

  • Materials Science
  • Engineering - Petroleum
  • Engineering - Chemical

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Au-Polydopamine integrated polycaprolactone-based 2D plasmonic nanofibrous bimodal platform for synergistically enhanced peripheral neuropathy and superior cancer theranostics’ [Materials Today Chemistry 41 (2024) 102294] (Materials Today Chemistry (2024) 41, (S2468519424004002), (10.1016/j.mtchem.2024.102294))'. Together they form a unique fingerprint.

Cite this